EVALUATION OF THE ROLE OF ALFLUTOP IN THE OSTEOARTHRITIS TREATMENT: INDICATIONS, CLINICAL EFFICACY, TOLERABILITY AND IMPACT ON QUALITY OF LIFE

Abstract

The main clinical manifestations of osteoarthritis (OA) are a painful articular syndrome of varying intensity accompanied by loss of functionality and impaired quality of life. The pathogenetic links of the degradation are related to violations of the hyaline cartilage structure. Collagen defects are practically not restored, worsening the dysfunction of joints. Alflutop is the cartilage protector, including chondroitin sulfate. In the literature its symptom - and the structure-modifying effect is shown. In the study we conducted in 60 patients the dynamics of painful articular syndrome, functional features and the quality of life of patients in case of complex treatment with alflutop were studied.

Keywords

• knee osteoarthritis
• cartilage degradation pathogenesis
• chondroitin sulfate
• alflutop